PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Dehydrocrenatidine Inhibits Voltage-Gated Sodium Channels and Ameliorates Mechanic Allodia in a Rat Model of Neuropathic Pain.

Rat / Other

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31003411 ↗2019Reported benefit

Dehydrocrenatidine Inhibits Voltage-Gated Sodium Channels and Ameliorates Mechanic Allodia in a Rat Model of Neuropathic Pain.

RatOtherSprague-Dawleymalen = 5 groups of 9 rats each (n = 9 per group); electrophysiolog…intrathecal injection150 or 250 microgram/kg14 days after chronic constriction injury, once mechanical allodynia was establ…

Model: Chronic constriction injury (partial ligation) of the sciatic nerve, neuropathic pain

Chronic constriction injury reduced paw withdrawal threshold to 1.90 +/- 0.31 g versus 15.10 +/- 1.50 g in sham. Intrathecal dehydrocrenatidine dose-dependently reversed mechanical allodynia, with the 250 microgram/kg dose comparable to morphine 50 microgram/kg. DHCT suppressed TTX-S and TTX-R sodi…

Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.